Navigation Links
Video: 'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma
Date:9/1/2009

CHICAGO, Sept. 1 /PRNewswire/ -- Today Jack Mackenroth, from the hit reality television series "Project Runway," launched a new online video series, called "Living Positive By Design: Creating Positive Conversations," as part of his national HIV and AIDS education initiative. The Living Positive By Design campaign, supported by Merck & Co., Inc., and online videos aim to encourage thoughtful conversations about HIV and AIDS, to confront HIV stigma and motivate HIV-positive people to have a positive outlook on life while effectively managing their disease.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/merck/37842/

"While touring the United States for Living Positive By Design, and speaking about my experiences living with HIV for more than 20 years, I have met so many inspiring people who have devoted much of their lives to HIV awareness and service," said Mackenroth. "I am excited to share the discussions I have had with politicians, advocates, celebrities and HIV doctors with you, as part of my 'Living Positive By Design: Creating Positive Conversations' series, and hope that their touching personal stories will motivate others nationwide."

Now available online is the first ever "Living Positive By Design: Creating Positive Conversations" video from Chicago, IL, a city that is working to battle its high incidence of HIV and AIDS. The video features Jack interviewing the Assistant Commissioner for the Chicago Department of Public Health's STD/HIV/AIDS Division, Christopher Brown; the founder of Sweet Miss Giving's Bakery and Gifting, a bakery that benefits locals affected by HIV and AIDS; and local HIV specialist Dr. Daniel Berger of NorthStar Medical Center. The video features each of these public figures discussing important initiatives and achievements that have been made in an effort to help the local Chicago community affected by HIV and AIDS.

To download the "Living Positive By Design: Creating Positive Conversations" video and widget featuring Chicago interviews and learn more about the campaign, please visit: www.LivingPositiveByDesign.com.

Prevalence of HIV and AIDS

According to the Centers for Disease Control and Prevention (CDC), in 2006 there were more than one million Americans living with HIV and AIDS. In the same year, an estimated 56,000 new cases were diagnosed in the U.S. Forty-nine percent of new diagnoses were among African Americans and 50 percent were among men who have sex with men (MSM).

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

Forward-looking statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors and cautionary statements in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2008, and in any risk factors or cautionary statements contained in the Company's periodic reports on Form 10-Q or current reports on Form 8-K, which the Company incorporates by reference.


'/>"/>
SOURCE Merck & Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol
2. Video: HHS Launches Best Bones Forever!
3. Video: CVS/pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot
4. Video: RE-LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non-valvular Atrial Fibrillation Patients
5. Video: Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
6. Video: AstraZeneca Traveling Exhibit Helps Americans Understand and Manage Bipolar Depression
7. Video: School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign
8. Video: Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month
9. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
10. Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain
11. Video: Provectus Pharmaceuticals Updates Shareholders On 2009 Year-To-Date Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: